# FDA Inspection 1063515 - Wavelength Enterprises Ltd. - July 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/wavelength-enterprises-ltd/29969924-c8b1-420b-840c-922dc7cd7bf0
Source feed: FDA_Inspections

> FDA Inspection 1063515 for Wavelength Enterprises Ltd. on July 12, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063515
- Company Name: Wavelength Enterprises Ltd.
- Inspection Date: 2018-07-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1195097 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/wavelength-enterprises-ltd/e67b9639-59cb-4018-8b19-96fa252e9661)
- [FDA Inspection 823501 - 2013-03-14](https://www.keypedia.com/records/fda_inspections/wavelength-enterprises-ltd/530cf7fe-d3f5-4d60-bdec-3ecb13b00827)
- [FDA Inspection 650245 - 2010-02-04](https://www.keypedia.com/records/fda_inspections/wavelength-enterprises-ltd/0c2e73b5-7ccf-4b7a-b4cc-d2b70a24eb99)

Company: https://www.keypedia.com/companies/wavelength-enterprises-ltd/0dadc003-ee8a-423c-a341-0683806b3779

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c